Serum Institute of India

Cervavac: SII Launches India’s First Indigenously-Developed Vaccine for the Prevention of Cervical Cancer

The development of the vaccine is significant as cervical cancer is the second most prevalent cancer in India.

According to an estimate, around 1.25 lakh women are diagnosed with cervical cancer annually. Also, around 75,000 die from this disease in India.

View Post

SII Seeks Approval For Covishield Vaccine As Booster Dose Amid Omicron Variant Concerns

Drug manufacturer the Serum Institute of India (SII) has sought India’s drug regulator’s approval for the Covishield vaccine as a booster shot quoting adequate stock of the vaccine in the…

View Post

Hopeful Of Launching Covovax For Adults In October This Year, For Children In Q1-2022: Serum CEO

Serum Institute of India CEO Adar Poonawalla on Friday announced that he is hopeful that Covovax, another COVID-19 vaccine being manufactured by his company in India, will be launched in…

View Post

India’s Zydus Cadila Seeks Nod For Its 3-Dose, “Needle-Free” Vaccine

India’s Zydus Cadila has sought emergency use approval for its ZyCoV-D three-dose Covid shot that is the “world’s first Plasmid DNA vaccine”. The company said, it is a “needle-free” and…

View Post

Covishield Production In Full Swing In Pune, Says Adar Poonawalla

Production of COVID-19 vaccine Covishield is in full swing in Pune and he will review the operations once he is back in the country, announced Serum Institute of India’s chief…

View Post